Correct. Having spent the past 10 years working for a pharma company, I have gotten to know their schtick well. I just wonder how much was spent coining the term "Low-T". It sounds so much cooler than hypogonadism. I am heavily invested in an upstart pharma company whose lead product is an intranasal gel to treat Low-T. This looks very promising in Phase II trials and poses none of the threats, like a wife with a moustache that gels do.

The second product will treat female anorgasmia. I wonder what it will be called to attract the baby boomers to it.